Sarepta Therapeutics | Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
BioCryst Pharmaceuticals USD -2.54M 10.23M 2024-12
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Capricor Therapeutics USD -24.98M 17.28M 2025-03
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Esperion Therapeutics USD -16.03M 18.6M 2024-09
Gilead Sciences USD 2.96B 551M 2025-12
Incyte USD 383.88M 47.43M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ionis Pharmaceuticals USD -160.18M 300.02M 2025-09
Moderna USD -857M 597M 2025-12
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novavax USD -134.02M 296.12M 2024-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Tectonic Therapeutic USD -21.89M 440K 2025-09
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12


Sarepta Therapeutics Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.